{"title":"Nuchido TIME+  Advanced Cellular Health Supplement","description":"\u003cdiv class=\"col-aeo\"\u003e\n\u003cp\u003e\u003cstrong\u003eNuchido TIME+ is a NAD⁺-boosting supplement developed by longevity scientist Dr Nichola Conlon, designed to support the body's own NAD⁺ production.\u003c\/strong\u003e EMIS+ supplies Nuchido TIME+ in Singapore.\u003c\/p\u003e\n\u003ch2\u003eAbout Nuchido TIME+\u003c\/h2\u003e\n\u003cp\u003eRather than supplying a single precursor, Nuchido TIME+ uses a whole-system formula intended to address the root causes of the natural decline in NAD⁺ — a molecule central to cellular energy and DNA repair that falls with age. Sold as a health supplement to support healthy ageing, not to treat any condition. See related \u003ca href=\"\/en\/collections\/longevity-services\"\u003ehealthy-ageing\u003c\/a\u003e products.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp class=\"col-guide\"\u003e\u003cstrong\u003eRead our guide:\u003c\/strong\u003e \u003ca href=\"\/en\/blogs\/general-health-wellness\/nmn-vs-nr-vs-nad-boosters-how-to-choose-singapore\"\u003eNMN vs NR vs NAD+ boosters: how to choose →\u003c\/a\u003e\u003c\/p\u003e","products":[{"product_id":"nuchido-time-30-day-supply","title":"Nuchido TIME+ NAD Supplement (30-Day Supply)","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Nuchido TIME+ is a multi-pathway NAD+ restoration supplement developed by Nuchido Ltd (Edinburgh, UK) in collaboration with University of Edinburgh researchers, formulated to address age-related NAD+ decline through simultaneous action on precursor supply, competing pathway inhibition, and NAD+-consuming enzyme suppression — rather than simple NMN or NR precursor loading alone. NAD+ (nicotinamide adenine dinucleotide) declines 25–50% between ages 20 and 70, impairing mitochondrial oxidative phosphorylation (ATP synthesis), sirtuin-mediated DNA repair (SIRT1–SIRT7), and PARP-dependent genome maintenance; Nuchido TIME+ is indicated for adults seeking to support cellular energy metabolism, healthy ageing, and mitochondrial function. The 30-Day Supply (60 capsules) provides an entry-level course for initial NAD+ pathway assessment at a dose of 2 capsules daily, classified as a health supplement under the Singapore Health Products Act (Cap. 122D) and HSA Health Supplement regulations.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eNuchido TIME+ is a scientifically formulated NAD+ restoration supplement developed by Nuchido Ltd, a University of Edinburgh spinout founded on research into the systems biology of cellular ageing and NAD+ metabolism. NAD+ is a coenzyme present in every living cell, functioning as the central electron carrier in mitochondrial oxidative phosphorylation (the electron transport chain), as an obligatory substrate for sirtuins (SIRT1–SIRT7) — the class of NAD+-dependent deacylase enzymes that regulate gene expression, DNA damage repair, mitochondrial biogenesis, and metabolic homeostasis — and as the substrate for PARP enzymes (poly ADP-ribose polymerases) that detect and repair DNA strand breaks. Age-related NAD+ decline, documented at 25–50% reduction between ages 20 and 70 in multiple human tissue studies, compromises all three of these fundamental cellular maintenance processes.\u003c\/p\u003e\n\u003cp\u003eUnlike single-ingredient NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) supplements that supply only one NAD+ biosynthesis precursor, Nuchido TIME+ addresses the NAD+ pathway at multiple points: precursor supplementation to increase NAD+ biosynthesis input; inhibition of ACMSD (alpha-amino-beta-carboxymuconate-semialdehyde decarboxylase), which diverts tryptophan-derived intermediates away from NAD+ synthesis and towards non-productive catabolism; and suppression of CD38, a key NAD+-consuming ectoenzyme whose age-associated upregulation is a primary driver of NAD+ depletion in tissues. This multi-pathway approach is designed to elevate NAD+ more effectively and sustainably than precursor supplementation alone by simultaneously increasing synthesis input and reducing degradation output. The 30-Day Supply (60 capsules at 2 capsules per day) provides an initial course for evaluating individual response before committing to the 90-Day flagship subscription.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eBrand\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNuchido Ltd, Edinburgh, United Kingdom (University of Edinburgh spinout)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eProduct Name\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eNuchido TIME+ NAD Supplement — 30-Day Supply\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCapsules per Pack\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e60 capsules (2 capsules per day)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDuration\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e30-day supply\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eMechanism\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMulti-pathway NAD+ restoration: NAD+ precursor supply + ACMSD pathway inhibition + CD38 NAD+-consuming enzyme suppression\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTarget Pathways\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eMitochondrial oxidative phosphorylation (ATP synthesis); Sirtuin activation (SIRT1–SIRT7): DNA repair, metabolic regulation, mitochondrial biogenesis; PARP-dependent genome maintenance\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eDosage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e2 capsules daily with food, preferably morning; peak serum NAD+ metabolite levels at approximately 1–2 hours post-ingestion\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRegulatory — Singapore\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eClassified as a health supplement under the Singapore Health Products Act (Cap. 122D) and Health Products (Health Supplements) Regulations; HSA notification required; compliant with ASEAN Regulatory Guidelines for Traditional Medicines and Health Supplements\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003ePermitted Claims\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSupports cellular energy metabolism; supports mitochondrial function; supports healthy ageing. Medicinal claims (disease treatment\/prevention) are not permitted for health supplements under HSA regulations\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCountry of Origin\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUnited Kingdom\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eStorage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStore in a cool, dry place below 25°C, away from direct sunlight; keep out of reach of children\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eKey Applications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eCellular energy support in age-related NAD+ decline:\u003c\/strong\u003e Adults aged 35 and above experiencing fatigue, reduced exercise tolerance, or diminished cognitive function associated with mitochondrial energetic decline — for whom restoration of NAD+ to younger-adult levels may support subjective energy and metabolic function.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSirtuin pathway activation for healthy ageing:\u003c\/strong\u003e SIRT1 activation requires NAD+ as an obligatory substrate; SIRT1 regulates PGC-1α (mitochondrial biogenesis), FOXO3 (antioxidant defence, apoptosis regulation), and NF-κB (inflammatory gene expression). Supporting sirtuin function through NAD+ restoration is a mechanistically grounded approach to healthy ageing support.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial function maintenance:\u003c\/strong\u003e NAD+ is essential for Complex I and Complex III of the mitochondrial electron transport chain; NAD+ depletion impairs ATP synthesis efficiency, reducing the energy available for cellular repair, immune function, and metabolic regulation. Indicated for individuals with occupational, physical, or chronological demands on cellular energy systems.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003e30-day entry course before 90-day commitment:\u003c\/strong\u003e The 30-day supply (60 capsules) allows clinical assessment of individual tolerance and subjective response to NAD+ supplementation before transitioning to the cost-effective 90-day supply. Recommended as an initial trial for patients new to NAD+ pathway supplementation, particularly in Singapore's wellness medicine and longevity clinic context.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCorporate and institutional wellness programmes:\u003c\/strong\u003e Supplied to Singapore corporate wellness programmes, executive health screening clinics, and longevity medicine practices as a premium supplement component for employees and patients in high-cognitive-demand roles.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eQ: How does Nuchido TIME+ differ from single-ingredient NMN or NR supplements?\u003c\/strong\u003e\u003cbr\u003eA: Standard NMN or NR supplements provide a single NAD+ precursor, increasing biosynthesis input at one point in the Salvage pathway. Nuchido TIME+ addresses multiple regulatory nodes simultaneously: precursor supply, ACMSD pathway inhibition (redirecting tryptophan-derived intermediates towards NAD+ synthesis), and CD38 suppression (reducing NAD+ degradation). Age-related NAD+ depletion is driven both by declining synthesis and increasing degradation; addressing only the precursor side leaves the degradation driver unresolved. The theoretical advantage of multi-pathway intervention is a higher, more sustained NAD+ elevation compared to precursor-only supplementation.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the scientific basis for Nuchido TIME+?\u003c\/strong\u003e\u003cbr\u003eA: Nuchido Ltd was founded as a spinout of the University of Edinburgh, with scientific advisory input from researchers specialising in the systems biology of ageing and NAD+ metabolism. The company has conducted internal research on the multi-pathway NAD+ restoration approach. Peer-reviewed clinical data specifically on Nuchido TIME+ as a commercial product is limited in publicly available literature as of early 2026; the mechanistic rationale draws on published research on the roles of CD38 upregulation and ACMSD pathway competition in age-related NAD+ decline (Camacho-Pereira et al., Cell Metabolism 2016 on CD38; Rajman et al., Cell Metabolism 2018 on NAD+ and ageing). Consumers and clinicians seeking independent clinical trial data on this specific formulation should contact Nuchido Ltd directly for any available unpublished study data.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Is Nuchido TIME+ registered as a health supplement in Singapore?\u003c\/strong\u003e\u003cbr\u003eA: Nuchido TIME+ is classified as a health supplement under the Singapore Health Products Act (Cap. 122D) and the Health Products (Health Supplements) Regulations administered by the Health Sciences Authority (HSA). Health supplements in Singapore do not require pre-market approval but must be notified to HSA and comply with ingredient restrictions, labelling requirements, and permitted health claims per the ASEAN Regulatory Guidelines for Traditional Medicines and Health Supplements. Permitted claims relate to general wellbeing (e.g., \"supports cellular energy\") rather than disease treatment or prevention. EMIS sources and distributes Nuchido TIME+ through compliant channels in Singapore.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: What is the difference between the 30-Day and 90-Day supply?\u003c\/strong\u003e\u003cbr\u003eA: The 30-Day Supply (60 capsules) provides a one-month initial course at 2 capsules daily — intended for individuals trialling NAD+ supplementation for the first time or assessing individual response and tolerance. The 90-Day Supply (180 capsules) is the flagship format, providing a sustained 3-month course which aligns with the timeframe for measurable changes in mitochondrial biogenesis and sirtuin-dependent cellular remodelling processes. For ongoing supplementation, the 90-day format offers improved cost-per-day and reduces interruptions in the supplementation schedule.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eQ: Are there any contraindications or interactions to be aware of in the Singapore clinical context?\u003c\/strong\u003e\u003cbr\u003eA: As a health supplement, Nuchido TIME+ has not undergone the clinical trial programme required for pharmaceutical registration. Individuals on prescription medications — particularly those modulating PARP, sirtuin, or mTOR pathways (e.g., cancer therapies, immunosuppressants) — should consult their physician before commencing NAD+ supplementation. Nicotinamide-based compounds are generally well-tolerated; transient flushing is more commonly associated with nicotinic acid (niacin) than with NMN or NR at standard doses. Pregnant or breastfeeding individuals should avoid NAD+ supplements in the absence of specific safety data. Advice should be sought from a Singapore-registered pharmacist or physician for personalised assessment.\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003eAvailable in Singapore from EMIS (Essential Medical International Supplies Pte Ltd), 30-Day Supply (60 capsules). For clinic stock, corporate wellness, or B2B procurement enquiries, contact our team at emis.asia.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003cscript type=\"application\/ld+json\"\u003e\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@type\": \"FAQPage\",\n  \"mainEntity\": [\n    {\n      \"@type\": \"Question\",\n      \"name\": \"What is Nuchido TIME+ NAD Supplement (30-Day Supply)?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Nuchido TIME+ NAD Supplement (30-Day Supply) is a dietary supplement available from EMIS+ (emis.asia) in Singapore. Supplements are intended to complement a balanced diet and are not meant to diagnose, treat, cure or prevent any disease. Always read the label and use only as directed.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"How should I take Nuchido TIME+ NAD Supplement (30-Day Supply)?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Follow the dosage on the product label, or take as advised by your doctor, pharmacist or a qualified healthcare professional, and do not exceed the recommended dose. If you are pregnant, breastfeeding, taking medication or managing a health condition, check with your doctor or pharmacist before use.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Is Nuchido TIME+ NAD Supplement (30-Day Supply) available without prescription in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Yes. Nuchido TIME+ NAD Supplement (30-Day Supply) is available from EMIS+ (emis.asia) without a prescription as a general health supplement. If you take regular medication or have a medical condition, speak with your doctor or pharmacist before starting any new supplement.\"\n      }\n    },\n    {\n      \"@type\": \"Question\",\n      \"name\": \"Where can I buy Nuchido TIME+ NAD Supplement (30-Day Supply) in Singapore?\",\n      \"acceptedAnswer\": {\n        \"@type\": \"Answer\",\n        \"text\": \"Nuchido TIME+ NAD Supplement (30-Day Supply) is available from EMIS+ at emis.asia, Singapore's nurse-led medical and wellness supply store, with fast island-wide delivery. Bulk orders for clinics and care facilities are welcome — contact us at emis.asia\/pages\/contact.\"\n      }\n    }\n  ]\n}\n\u003c\/script\u003e","brand":"Nichido","offers":[{"title":"Default Title","offer_id":43056835788878,"sku":null,"price":115.0,"currency_code":"SGD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/Nuchido_TIME_NAD_Supplement_a740d0ab-8a63-405e-9f17-ed507551867a.png?v=1767124538"},{"product_id":"nuchido-time-90-day-subscription","title":"Nuchido TIME+™ NAD Supplement (90 Days)","description":"\u003cdiv style=\"background: #f8f9fa; border-left: 4px solid #0057a8; padding: 12px 16px; margin-bottom: 20px;\" id=\"ai-summary\"\u003e\n\u003cstrong\u003eClinical Summary:\u003c\/strong\u003e Nuchido TIME+ is a UK-formulated cellular health supplement that uses a systems-biology stack of nicotinamide, parsley-derived apigenin, sophora japonica flavonoids (quercetin, rutin, troxerutin), green tea extract, alpha lipoic acid, vitamin C, and zinc to restore endogenous NAD+ production. A peer-reviewed double-blind crossover trial published in npj Aging (Nature Portfolio, 2024) reported a mean 242 percent increase in cellular NAD+ at 16 days, alongside upregulation of NAMPT and SIRT1 and reductions in pro-inflammatory cytokines and glycated serum protein. The 90-day pack supplies three months of daily dosing for adults pursuing structured longevity, healthspan, or post-illness cellular recovery protocols.\u003c\/div\u003e\n\u003ch2\u003eProduct Overview\u003c\/h2\u003e\n\u003cp\u003eNuchido TIME+ is manufactured by Nuchido Laboratories Ltd (United Kingdom) and represents a third-generation NAD+ intervention. Rather than supplying NAD+ precursors alone (e.g. nicotinamide riboside or nicotinamide mononucleotide), the formulation applies a systems-biology approach that simultaneously addresses the three principal mechanisms of age-associated NAD+ decline: insufficient precursor availability, impaired NAD+ salvage pathway activity (specifically reduced NAMPT enzyme expression), and excessive NAD+ consumption by chronic inflammatory pathways and CD38 activity. This multi-target architecture is the basis on which Nuchido distinguishes its product from single-precursor competitors.\u003c\/p\u003e\n\u003cp\u003eThe 90-day pack contains three monthly bottles supplying a continuous daily dose for adults aged 30 and above seeking to maintain or restore cellular NAD+ levels. The clinical evidence base includes a randomised, double-blind, crossover human trial (Dollerup et al., npj Aging, 2024) in 26 participants aged 20-80 years, demonstrating significant elevation of whole-blood NAD+, increased SIRT1 and NAMPT expression in peripheral blood mononuclear cells, reduction in plasma pro-inflammatory cytokines including IL-2, and a measurable decrease in glycated serum protein, indicating downstream metabolic benefit.\u003c\/p\u003e\n\u003ch2\u003eSpecifications\u003c\/h2\u003e\n\u003ctable style=\"border-collapse: collapse; width: 100%;\" cellspacing=\"0\" cellpadding=\"6\" border=\"1\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eManufacturer\u003c\/th\u003e\n\u003ctd\u003eNuchido Laboratories Ltd, United Kingdom\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003ePack Size\u003c\/th\u003e\n\u003ctd\u003e90-day supply (3 x 30-day bottles, monthly subscription or one-off purchase)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eDaily Dose\u003c\/th\u003e\n\u003ctd\u003e2 capsules with breakfast\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eActive Ingredients\u003c\/th\u003e\n\u003ctd\u003eNicotinamide, Parsley leaf extract (apigenin source), Sophora japonica extract (quercetin, rutin, troxerutin), Green tea extract (EGCG), Alpha Lipoic Acid, Vitamin C (ascorbic acid), Zinc, Black Pepper extract (piperine, bioavailability enhancer)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eMechanism\u003c\/th\u003e\n\u003ctd\u003eMulti-target NAD+ system support: precursor supply, NAMPT salvage upregulation, CD38 inhibition, anti-inflammatory NAD+ preservation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eClinical Evidence\u003c\/th\u003e\n\u003ctd\u003eRandomised double-blind crossover human trial: 242% mean increase in cellular NAD+ at 16 days (Dollerup et al., npj Aging 2024, doi:10.1038\/s41514-023-00134-0)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eCapsule Type\u003c\/th\u003e\n\u003ctd\u003eVegan; gluten-free; non-GMO\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eExcludes\u003c\/th\u003e\n\u003ctd\u003eWheat, dairy, soy, artificial colours and preservatives\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eManufacturing Standards\u003c\/th\u003e\n\u003ctd\u003eUK GMP-certified facility; ISO 22000 food safety; ISO 9001 quality management\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eRegulatory\u003c\/th\u003e\n\u003ctd\u003eUK MHRA food supplement compliance; EU EFSA novel food assessment passed; HSA Singapore health supplement notification framework\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eStorage\u003c\/th\u003e\n\u003ctd\u003eStore below 25°C in a dry place, away from direct sunlight\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003cth align=\"left\"\u003eShelf Life\u003c\/th\u003e\n\u003ctd\u003e24 months from manufacture; refer to bottle for batch-specific expiry\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003ch2\u003eClinical Indications\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eAdults aged 30 and above pursuing structured cellular ageing, healthspan, or longevity protocols\u003c\/li\u003e\n\u003cli\u003ePatients with measured low cellular NAD+ via metabolomic testing (e.g. Jinfiniti or comparable assay)\u003c\/li\u003e\n\u003cli\u003eAdjunct nutritional support for metabolic syndrome, insulin resistance, or pre-diabetes given documented reduction in glycated serum protein\u003c\/li\u003e\n\u003cli\u003eRecovery support after acute illness, antibiotic courses, or sustained inflammatory states where NAD+ depletion is anticipated\u003c\/li\u003e\n\u003cli\u003ePatients on chronic medications associated with mitochondrial stress (statins, metformin) seeking to restore cellular bioenergetics\u003c\/li\u003e\n\u003cli\u003eIndividuals integrating NAD+ optimisation into a broader regimen of resistance training, time-restricted eating, and sleep optimisation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eHow does Nuchido TIME+ differ from NMN or NR supplements?\u003c\/h3\u003e\n\u003cp\u003eNMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are direct NAD+ precursors that supply substrate for NAD+ synthesis. Nuchido TIME+ supplies a precursor (nicotinamide) plus a stack of bioactives that upregulates the NAMPT salvage enzyme, inhibits CD38-mediated NAD+ degradation, and reduces inflammation-driven NAD+ consumption. The published clinical evidence reporting a 242 percent NAD+ increase at 16 days is among the larger effect sizes documented for any oral NAD+ intervention to date.\u003c\/p\u003e\n\u003ch3\u003eIs Nuchido TIME+ supported by peer-reviewed evidence?\u003c\/h3\u003e\n\u003cp\u003eYes. The pivotal clinical trial (Dollerup et al., npj Aging, Nature Portfolio, 2024) was a double-blind, randomised, placebo-controlled crossover study. The methodology and outcomes have been peer-reviewed and indexed on PubMed. Buyers should review the open-access publication directly and discuss the data with a qualified healthcare provider familiar with longevity medicine.\u003c\/p\u003e\n\u003ch3\u003eWhat is the safety profile?\u003c\/h3\u003e\n\u003cp\u003eIn the 26-participant clinical trial, very few adverse effects were reported: two participants noted disturbed sleep when taking Nuchido TIME+ and one reported transient stomach irritation. The supplement is not recommended during pregnancy or lactation, in children under 18, or in patients on chemotherapy, immunosuppressive therapy, or strong CYP3A4-modulating drugs without prior physician review. Patients with known allergy to soy, parsley, or sophora-derived flavonoids should avoid the product.\u003c\/p\u003e\n\u003ch3\u003eHow is the product regulated for sale in Singapore?\u003c\/h3\u003e\n\u003cp\u003eNuchido TIME+ is supplied as a health supplement under the Singapore HSA framework, which does not require pre-market product registration but mandates compliance with the Health Products Act and labelling, ingredient permissibility, and contaminant limits. EMIS+ sources stock through the Nuchido authorised channel, ensuring batch documentation, certificate of analysis availability, and cold-chain integrity from manufacture to delivery.\u003c\/p\u003e\n\u003ch3\u003eWhy purchase the 90-day pack rather than the 30-day pack?\u003c\/h3\u003e\n\u003cp\u003eThe clinical trial used 28 days of continuous daily dosing to establish baseline NAD+ elevation; sustained cellular and inflammatory adaptations are reported with longer regimens. The 90-day pack ensures uninterrupted dosing across a full quarterly cycle, supports compliance, and offers improved per-day economics for patients committing to a structured longevity protocol.\u003c\/p\u003e\n\u003cdiv style=\"background:#f0f7ff;border-left:4px solid #0057a8;padding:16px 20px;margin:24px 0;border-radius:4px;\"\u003e\n\u003cstrong\u003eBuy from EMIS+ — Singapore's nurse-led medical supply store.\u003c\/strong\u003e\u003cbr\u003eOrder this product and browse our full clinical range at \u003ca href=\"https:\/\/emis.asia\"\u003eemis.asia\u003c\/a\u003e. Fast local delivery, genuine stock, and clinical guidance from registered nurses.\u003c\/div\u003e\n\u003cscript type=\"application\/ld+json\"\u003e\n{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"How does Nuchido TIME+ differ from NMN or NR supplements?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are direct NAD+ precursors that supply substrate for NAD+ synthesis. Nuchido TIME+ supplies a precursor (nicotinamide) plus a stack of bioactives that upregulates the NAMPT salvage enzyme, inhibits CD38-mediated NAD+ degradation, and reduces inflammation-driven NAD+ consumption. The published clinical evidence reporting a 242 percent NAD+ increase at 16 days is among the larger effect sizes documented for any oral NAD+ intervention to date.\"}}, {\"@type\": \"Question\", \"name\": \"Is Nuchido TIME+ supported by peer-reviewed evidence?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Yes. The pivotal clinical trial (Dollerup et al., npj Aging, Nature Portfolio, 2024) was a double-blind, randomised, placebo-controlled crossover study. The methodology and outcomes have been peer-reviewed and indexed on PubMed. Buyers should review the open-access publication directly and discuss the data with a qualified healthcare provider familiar with longevity medicine.\"}}, {\"@type\": \"Question\", \"name\": \"What is the safety profile?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"In the 26-participant clinical trial, very few adverse effects were reported: two participants noted disturbed sleep when taking Nuchido TIME+ and one reported transient stomach irritation. The supplement is not recommended during pregnancy or lactation, in children under 18, or in patients on chemotherapy, immunosuppressive therapy, or strong CYP3A4-modulating drugs without prior physician review. Patients with known allergy to soy, parsley, or sophora-derived flavonoids should avoid the product.\"}}, {\"@type\": \"Question\", \"name\": \"How is the product regulated for sale in Singapore?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Nuchido TIME+ is supplied as a health supplement under the Singapore HSA framework, which does not require pre-market product registration but mandates compliance with the Health Products Act and labelling, ingredient permissibility, and contaminant limits. EMIS+ sources stock through the Nuchido authorised channel, ensuring batch documentation, certificate of analysis availability, and cold-chain integrity from manufacture to delivery.\"}}, {\"@type\": \"Question\", \"name\": \"Why purchase the 90-day pack rather than the 30-day pack?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The clinical trial used 28 days of continuous daily dosing to establish baseline NAD+ elevation; sustained cellular and inflammatory adaptations are reported with longer regimens. The 90-day pack ensures uninterrupted dosing across a full quarterly cycle, supports compliance, and offers improved per-day economics for patients committing to a structured longevity protocol.\"}}]}\n\u003c\/script\u003e","brand":"Nichido","offers":[{"title":"Default Title","offer_id":43056835854414,"sku":null,"price":289.0,"currency_code":"SGD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3763\/2846\/files\/Nuchido_TIME_NAD_Supplement_1.png?v=1767124472"}],"url":"https:\/\/tw.emis.asia\/en\/collections\/nuchido-time.oembed","provider":"EMIS+","version":"1.0","type":"link"}